|
PPIL4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.50459997186425E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.61820000019486E-08 |
| Normal-vs-Stage2 |
2.22020002382806E-09 |
| Normal-vs-Stage3 |
5.93250004676804E-10 |
| Normal-vs-Stage4 |
3.46930040251436E-10 |
| Stage1-vs-Stage2 |
1.936030E-02 |
| Stage1-vs-Stage3 |
3.270400E-02 |
| Stage1-vs-Stage4 |
1.407710E-02 |
| Stage2-vs-Stage3 |
4.749000E-01 |
| Stage2-vs-Stage4 |
7.918000E-01 |
| Stage3-vs-Stage4 |
6.363200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.54319998393981E-09 |
| Normal-vs-AfricanAmerican |
1.939530E-03 |
| Normal-vs-Asian |
1.58617000000083E-05 |
| Caucasian-vs-AfricanAmerican |
3.377200E-01 |
| Caucasian-vs-Asian |
1.976610E-01 |
| AfricanAmerican-vs-Asian |
8.396200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.80259976021591E-10 |
| Normal-vs-Female |
6.29910001936906E-09 |
| Male-vs-Female |
2.580600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.30570000034247E-07 |
| Normal-vs-Age(41-60Yrs) |
3.75709996447426E-09 |
| Normal-vs-Age(61-80Yrs) |
3.85700360538976E-11 |
| Normal-vs-Age(81-100Yrs) |
3.919300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.565980E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.040000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.736800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.486000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.957200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.407400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.194500E-02 |
| Classical-VS-Follicular |
2.105000E-03 |
| Classical-VS-Other |
4.692200E-01 |
| Classical-VS-Normal |
3.03119999989221E-07 |
| Tall-VS-Follicular |
8.668600E-01 |
| Tall-VS-Other |
6.914400E-01 |
| Tall-VS-Normal |
4.81889994574658E-09 |
| Follicular-VS-Other |
7.031600E-01 |
| Follicular-VS-Normal |
3.18259862908121E-11 |
| Other-VS-Normal |
1.013990E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.295763827462E-14 |
| Normal-vs-N1 |
1.40010000260204E-08 |
| N0-vs-N1 |
9.338000E-01 |
|
|
